ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,332Medicare Part D Prescriptions Filled, Including Refills

Rank: 24 out of 1107

$1.49M Total Retail Price of All Prescriptions

Rank: 27 out of 1107

755 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
57% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 755 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

36% of this provider’s 755 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 22,048 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 1,817 1,228 S3 1 1
LISINOPRIL 1,133 890 2 2
LEVOTHYROXINE SODIUM 943 759 3 3
FUROSEMIDE 767 683 4 7
OMEPRAZOLE 747 597 5 4
SIMVASTATIN 586 497 6 5
AMLODIPINE BESYLATE 557 468 7 6
GABAPENTIN 533 364 8 9
METFORMIN HCL 512 354 9 8
WARFARIN SODIUM 487 433 10 15
PRAVASTATIN SODIUM 469 353 11 12
CITALOPRAM HBR 414 345 12 17
METOPROLOL SUCCINATE 386 279 13 16
ISOSORBIDE MONONITRATE ER 373 353 14 34
RANITIDINE HCL 331 222 15 21
POTASSIUM CHLORIDE 317 275 16 14
CARVEDILOL 291 261 17 27
POLYETHYLENE GLYCOL 3350 284 242 18 46
CLOPIDOGREL 283 228 19 28
GLIMEPIRIDE 267 242 20 43
METFORMIN HCL ER 263 170 21 58
ATORVASTATIN CALCIUM 262 239 22 13
METOPROLOL TARTRATE 254 211 23 10
LANTUS 252 222 24 49
DONEPEZIL HCL 249 244 25 32
PAROXETINE HCL 231 158 26 45
HYDROCHLOROTHIAZIDE 224 169 27 11
FLUTICASONE PROPIONATE 223 169 28 38
PROMETHAZINE HCL 219 109 R 29 44
NEXIUM 216 136 30 18
LOSARTAN POTASSIUM 208 181 31 29
ROPINIROLE HCL 204 160 32 69
TRAMADOL HCL 196 134 33 26
ZOLPIDEM TARTRATE 180 95 34 22
LACTULOSE 176 163 35 89
DIGOXIN 174 157 36 52
SERTRALINE HCL 173 145 37 20
INSULIN SYRINGE 173 129 37 78
PLAVIX 173 142 37 39
OXYCODONE HCL 169 140 S2 40 100
ATENOLOL 167 145 41 19
TAMSULOSIN HCL 166 150 42 30
FINASTERIDE 165 158 43 130
MELOXICAM 161 126 44 25
NAMENDA 149 149 45 42
PREDNISONE 148 120 46 40
MIRTAZAPINE 147 127 47 61
FLUOXETINE HCL 147 112 47 47
PANTOPRAZOLE SODIUM 146 93 49 30
OXYCODONE HCL-ACETAMINOPHEN 144 96 S2 50 93
QUETIAPINE FUMARATE 134 110 51 94
TRAZODONE HCL 131 93 52 33
CYCLOBENZAPRINE HCL 128 46 R 53 56
CYMBALTA 128 85 53 50
NOVOLIN R 127 118 55 187
CLONIDINE HCL 119 89 56 53
LEVOFLOXACIN 116 99 57 71
PROAIR HFA 116 55 57 37
RISPERIDONE 115 105 59 79
DILTIAZEM 24HR CD 113 111 60 126
DIVALPROEX SODIUM 111 63 61 96
ADVAIR DISKUS 109 101 62 54
ALENDRONATE SODIUM 107 99 63 41
LISINOPRIL-HYDROCHLOROTHIAZIDE 106 95 64 24
DOXYCYCLINE HYCLATE 105 83 65 128
ALLOPURINOL 102 52 66 36
DILTIAZEM ER 100 88 67 139
NYSTATIN 98 91 68 110
CRESTOR 98 69 68 23
EXELON 92 92 70 103
HYDRALAZINE HCL 91 89 71 99
LYRICA 90 73 72 83
LANSOPRAZOLE 90 54 72 102
ALBUTEROL SULFATE 89 87 74 144
FENOFIBRATE 89 72 74 67
VENLAFAXINE HCL ER 88 59 76 117
LABETALOL HCL 84 84 77 245
DILTIAZEM 24HR ER 84 83 77 172
ACETAMINOPHEN-CODEINE 83 80 S3 79 120
PREMARIN 82 59 R 80 149
KLOR-CON 10 81 72 81 143
AMIODARONE HCL 80 76 82 199
METOCLOPRAMIDE HCL 78 51 83 116
AZITHROMYCIN 77 51 84 35
ESCITALOPRAM OXALATE 76 45 85 82
AMITRIPTYLINE HCL 76 57 R 85 48
NITROGLYCERIN PATCH 75 72 87 184
LANTUS SOLOSTAR 75 43 87 129
LOSARTAN-HYDROCHLOROTHIAZIDE 73 61 89 66
LIPITOR 73 69 89 109
ONDANSETRON HCL 72 61 91 211
OXYCONTIN 72 0 S2 91 167
BUPROPION XL 72 64 91 200
HYDROXYZINE HCL 72 45 R 91 162
IBUPROFEN 72 37 91 63
NORTRIPTYLINE HCL 71 56 96 267
SPIRONOLACTONE 70 59 97 72
FLUCONAZOLE 69 43 98 150
METHYLPHENIDATE HCL 68 55 99 419
GLYBURIDE 67 46 R 100 68
OLANZAPINE 66 0 101 176
SULFAMETHOXAZOLE-TRIMETHOPRIM 66 47 101 88
GLIPIZIDE ER 66 50 101 115
SINGULAIR 65 57 104 65
PEN NEEDLE 63 29 105 192
SODIUM CHLORIDE 62 60 106 186
CIPROFLOXACIN HCL 59 42 107 59
NOVOLOG 58 41 108 127
CEFUROXIME 58 50 108 157
ABILIFY 58 37 108 170
CEFTRIAXONE 57 51 111 227
LIDODERM 57 37 111 140
OXYBUTYNIN CHLORIDE 56 36 113 171
NIFEDIPINE ER 55 51 114 168
DETROL LA 55 44 114 223
TRIAMCINOLONE ACETONIDE 54 44 116 137
GLIPIZIDE 54 51 116 64
LOPERAMIDE 54 34 116 229
KLOR-CON M20 54 47 116 75
SPIRIVA 54 49 116 57
VERAPAMIL ER 53 34 121 113
RISPERDAL CONSTA 53 53 121 263
ZETIA 52 52 123 76
RANEXA 52 44 123 272
MONTELUKAST SODIUM 52 37 123 118
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 14, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.